Riskpilot← Back to searchSign inGet full accessMOLECULE CONSULTANCY A/S
A/SActiveCVR 28515766Dampfærgevej 27, 5.Public relations and communication activities · NACE 7330Est. 200522 employees
Revenue 2024
DKK 14,4M
-12% vs 2023
EBITDA margin
0.8%
-71% vs 2023
Equity ratio
7.4%
Financial strength
Net profit 2024
DKK 122K
-70% vs 2023
| Revenue | DKK 14,4M | -12% |
| EBITDA | DKK 114K | -71% |
| Net profit | DKK 122K | -70% |
| Total assets | DKK 11,8M | -30% |
| Equity | DKK 872K | -25% |
| Employees | 22 | — |
Legal name
MOLECULE CONSULTANCY A/S
CVR number
28515766
Legal form
Aktieselskab
NACE code
7330 · Public relations and communication activities
Founded
23. marts 2005
Share capital
DKK 500.000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør, af to bestyrelsesmedlemmer i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive public relations-, kommunikations- og konsulentvirksomhed.
Address
Dampfærgevej 27, 5.
Phone
+4533131320
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.109 | 8.710 | 8.947 | 12.288 | 12.874 | 12.402 | 13.642 | 15.109 | 21.537 | 36.106 | 35.506 | 16.327 | 14.371 |
| Staff expenses | -6.540 | -5.878 | -5.075 | -4.924 | -6.204 | -7.170 | -7.925 | -8.350 | -11.051 | -16.925 | -17.181 | -15.940 | -14.257 |
| EBITDA | -2.062 | 553 | 519 | 2.947 | 2.753 | 1.616 | 1.681 | 1.834 | 3.465 | 7.305 | 4.181 | 387 | 114 |
| Depreciation & amort. | -195 | -87 | -22 | -11 | -3 | -6 | -9 | -0 | -0 | -0 | -0 | -4 | -17 |
| EBIT | -2.257 | 466 | 497 | 2.936 | 2.750 | 1.610 | 1.672 | 1.834 | 3.465 | 7.305 | 4.181 | 383 | 97 |
| Net financials | -85 | -548 | -131 | -50 | -50 | -15 | -24 | -16 | -49 | -61 | -41 | 110 | 62 |
| Profit before tax | -2.342 | -82 | 366 | 2.886 | 2.700 | 1.595 | 1.648 | 1.818 | 3.416 | 7.244 | 4.140 | 493 | 159 |
| Tax | -601 | 77 | 92 | 680 | 592 | 351 | 363 | 401 | 752 | 1.596 | 923 | 88 | 37 |
| Net profit | -1.741 | -159 | 274 | 2.206 | 2.108 | 1.244 | 1.285 | 1.417 | 2.664 | 5.648 | 3.217 | 405 | 122 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.248 | 2.971 | 4.196 | 5.620 | 7.061 | 8.272 | 7.974 | 9.972 | 22.466 | 21.349 | 14.299 | 16.932 | 11.825 |
| Equity | -3.139 | -3.298 | -3.016 | -810 | 1.298 | 2.542 | 2.035 | 2.167 | 3.414 | 6.398 | 3.967 | 1.155 | 872 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 201 | 646 | 0 | 0 | 0 | 0 |
| Short-term debt | 5.387 | 6.243 | 7.212 | 6.430 | 5.609 | 5.631 | 5.790 | 7.373 | 18.017 | 14.463 | 9.973 | 15.505 | 10.694 |
| Total debt | 5.387 | 6.243 | 7.212 | 6.430 | 5.609 | 5.631 | 5.790 | 7.574 | 18.663 | 14.463 | 9.973 | 15.505 | 10.694 |
EBITDA margin
0.8%
This company
15.8%
Market median
-95% vs market
20122024
Equity ratio
7.4%
This company
38.2%
Market median
-81% vs market
20122024
Return on equity
14.0%
This company
18.4%
Market median
+24% vs market
20122024
Net profit margin
0.8%
This company
8.1%
Market median
-90% vs market
20122024
Asset turnover
1.22×
This company
1.12×
Market median
+9% vs market
20122024
Debt / equity
12.56×
This company
0.62×
Market median
-1926% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Management | Management | 2005 | — | — |
SB Management | Management | 2005 | — | — |
MT Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
BA Management | Management | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2005 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2016 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2005 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Molecule Holding A/S | Company | 50.0% | 50.0% | 2021 |
MTSØRENSEN HOLDING ApS | Company | 20.0% | 20.0% | 2020 |
| Individual | 10.0% | 10.0% | 2021 | |
VRIML ApS | Company | 5.0% | 5.0% | 2026 |
| Individual | 5.0% | 5.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Molecule Holding A/S
MOLECULE CONSULTANCY A/S Board members of MOLECULE CONSULTANCY A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annemette Heller | Management | 0 companies |
| Søren Berzant | Management | 0 companies |
| Mette Thorn Sørensen | Chief Executive Officer | 0 companies |
| Bo Anders Cnattingius | Management | 0 companies |
| Carl Erik Kjærsgaard | Chairman | 0 companies |
| Morten Vestergren Frederiksen | Chairman | 0 companies |
| Steffen Pierini Lüders | Board of Directors | 0 companies |
| Viki Rachlitz | Board of Directors | 0 companies |
| Mads Aagaard Winther | Chairman | 0 companies |
| Rolf Bach Christensen | Chairman | 0 companies |
| Kim Madsen | Chairman | 0 companies |